• Extension of Sunshine Reporting to NPs and PAs • Recent Enforcement Initiatives and Proposed Changes in Regulations • Trends in State-By-State Reporting • Updates on Medical Device Reporting • Data Privacy Deep Dive • The Story behind Your Organization’s Data for Efficient Utilization • Emerging Global Transparency Guidelines and Cross-Border Management • Regulatory Frameworks to Successfully Manage HCP Interactions • Updates on Price Transparency Reporting • Third-Party Data Validation and Monitoring • Compliance Risk Measures of Speaker Programs • Metrics and Data Analytics to Ensure Compliance ALL NEW PROGRAMMING FOR 2020! Benefit from devoted, customizable tracks on: Industry’s Largest, Longest-Running and Most Anticipated Event Delivers Best Practices to Streamline the Submission Process and Leverage Data Analytics to Drive Compliant Operations WWW.CBINET.COM/AGGSPEND T T ransparency & Aggregate Spend 14th Annual Forum on AUGUST 12-14, 2020 | THE RITZ-CARLTON | WASHINGTON, DC Definitive Solutions and Trends for High-Risk Areas in State, Open Payments and Global Reporting Requirements Brought to you by an informa business HCP Risk Management Data Analytics Global Transparency COMPLIANCE & LEGAL SERIES
7
Embed
Transparency 14th Annual Forum on Aggregate Spend › sites › default › files › files › PC20156... · 2020-03-25 · Medicines for Europe Margaret Rossini, Director, Corporate
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
• Extension of Sunshine Reporting to NPs and PAs
• Recent Enforcement Initiatives and Proposed Changes in Regulations
• Trends in State-By-State Reporting
• Updates on Medical Device Reporting
• Data Privacy Deep Dive
• The Story behind Your Organization’s Data for Efficient Utilization
• Emerging Global Transparency Guidelines and Cross-Border Management
• Regulatory Frameworks to Successfully Manage HCP Interactions
• Updates on Price Transparency Reporting
• Third-Party Data Validation and Monitoring
• Compliance Risk Measures of Speaker Programs
• Metrics and Data Analytics to Ensure Compliance
ALL NEW PROGRAMMING FOR 2020!Benefit from devoted, customizable tracks on:
Industry’s Largest, Longest-Running and Most Anticipated Event Delivers Best Practices to Streamline the Submission Process and Leverage Data Analytics to Drive Compliant Operations
W W W.CBINET.COM/AGGSPEND
TTransparency & Aggregate Spend
14th Annual Forum on
AUGUST 12-14, 2020 | THE RITZ-CARLTON | WASHINGTON, DC
Definitive Solutions and Trends for High-Risk Areas in State, Open Payments and Global Reporting Requirements
Brought to you by
an informa business
HCP Risk Management
Data Analytics
Global Transparency
COMPLIANCE & LEGAL SERIES
Day One — Tuesday, August 11, 2020 7:30 Workshop Registration
8:30
CHOOSE BETWEEN 1 OF THE 3 CONCURRENT WORKSHOPS (A-C)
Device, Dental and Distributor Transparency ReportingA Speaker Program Monitoring B Third-Party Risk
Management and Oversight C10:30 Networking and Refreshment Break
12:00 Close of Pre-Conference Workshops, Networking Luncheon Commences
12:30 Afternoon Summit Registration
1:30
CHOOSE BETWEEN 1 OF THE 2 CONCURRENT AFTERNOON SUMMITS (I-II)
Guidebook for Beginner’s on Open Payments Reporting I Closed-Door Open Payments Summit —
Prelude for ExpertsII3:00 Networking and Refreshment Break
5:00 Networking Wine and Cheese Reception
Day Two — Wednesday, August 12, 2020 7:15 Main Conference Registration and Continental Breakfast
8:15 Conference Chair’s Welcome and Opening Remarks
8:30 CMS Town Hall — Keynote Address and Panel Discussion
9:30 PANEL DISCUSSION • Execution of the Sunshine Act Expansion
10:15 Networking and Refreshment Break
10:45 ENFORCEMENT AND INDUSTRY PANEL DISCUSSION • The Latest on Government Expectations vs. Reality and High-Risk Areas to Closely Monitor
11:45 PANEL DISCUSSION • Spotlight on Price Transparency Reporting — Impactful Trends to Know
12:30 Networking Luncheon
1:45 WORKSTREAMS COMMENCE — CHOOSE TO ATTEND 1 OF THE 3 CONCURRENT WORKSTREAMS (I- I I I)
1:45 Reduce Risk and Maximize Compliance Across the HCP/HCO Engagement Process
2:30 Examine the Impact of FCPA on HCP Interactions
3:15 Networking and Refreshment Break
3:45 Overcome Challenges in Contract Management to Streamline HCP Operations
4:30 Assess the HCP FMV Framework
1:45 PANEL DISCUSSION • Essential Overview of the Country-by-Country Landscape
2:30 Assess Various Technologies to Support Global Transparency Reporting
3:15 Networking and Refreshment Break
3:45 Best Practices for Navigating Consent and Cross-Border Management
4:30 Examine the Updates on Medical Device — Global Transparency Reporting
1:45 Ensure Quality of Data Collection and Systems
2:30 Explore the Use of A.I. in Compliance Programs
3:15 Networking and Refreshment Break
3:45 Streamline Customer Master Data Management
4:30 Examine the Utilization of Transparency Data to Mitigate Risk
I. Risk Management in HCP Interactions II. Global Transparency Reporting III. Data Collection, Analytics and A.I.
5:15 Close of Day Two / Wine and Cheese Networking Reception
AGENDA AT-A-GLANCE
Day Three — Thursday, August 13, 2020 7:30 Continental Breakfast
8:00 Conference Chair’s Review of Day Two
8:15 ABPI Address — UK’s Disclosure Experience and Updates to the ABPI Code
9:15 Gain Critical Insights into the Current Data Privacy Landscape
10:00 Networking and Refreshment Break
10:30 WORKSTREAMS COMMENCE — CHOOSE TO ATTEND 1 OF THE 3 CONCURRENT WORKSTREAMS (I- I I I)
10:30 Key Strategies for Managing Global HCP Activities
11:15 Effective Strategies to Streamline HCP Dispute Management
10:30 101 — How to Get Started on Implementing Global Data Analytics
11:15 Benchmark with Industry Peers on Global Patient Organization Reporting
10:30 CMS Review — Keys to Preparing and Reporting for CMS Audits
11:15 Post CIA — Lessons Learned to Remain Compliant
I. Risk Management in HCP Interactions II. Global Transparency Reporting III. Data Collection, Analytics and A.I.
12:00 Networking Luncheon
1:45 Practical Strategies for Properly Capturing and Reporting T&E Spend
2:45 Leverage Transparency Data for Informed Business Decisions
3:30 Close of Conference
Great conference! The content that was presented was very
beneficial and relevant!– Manager, Aggregate Spend,
Mallory O’Connor, Director Of Public Policy, Mallinckrodt Pharmaceuticals
Michael O’Connor, Vice President of Compliance Technology, Porzio Life Sciences, LLP
John Oroho, Executive Vice President & Chief Strategy Officer, Porzio Life Sciences, LLC
Mohammad Ovais, CEO, qordata
Michael Pace Senior Director, Enterprise Sales – Life Sciences Market, U.S., SAP Concur
Jennifer Parsons, Director, US Transparency & Compliance Operations, Biogen
April Pierce, Associate Director, Global Spend Transparency, Sage Therapeutics
Andrea Pucci, Senior Legal & Compliance Advisor, Medicines for Europe
Margaret Rossini, Director, Corporate Compliance Monitoring and Risk, Sandoz Inc.
Carol M. Seaman, Vice President, Global Chief Ethics & Compliance Officer, Cook Group
Brian Sharkey, Vice President, Porzio Life Sciences, LLP
Emily Singh, Director, PwC
Rhonda Sobral O’Toole, Esq., Director, Compliance Reporting and Systems, Ferring Pharmaceuticals Inc.
Bryan Stefanski, Compliance Director, Siemens Medical Solutions USA, Inc.
Tom Sullivan, President, Policy & Medicine
Wendy Sward, Senior Solution Consultant, Life Sciences, SAP Concur
Kelly Tope, Esq., MBA, Global Director, Compliance, Zimmer Biomet
Jeffrey Trull, Global Transparency/Financial Systems Manager, Covance, Inc.
Robin Usi, Director, Division of Data and Informatics, Center for Program Integrity, Data Sharing and Partnership Group, Centers for Medicare and Medicaid Services (CMS)
David Vulcano, Vice President, Research, Compliance, & Integrity, HCA Healthcare
Matt Wetzel, Senior Counsel, Akin Gump Strauss Hauer & Feld LLP, Former Vice President & Deputy General Counsel, AdvaMed
Donna White, Vice President, Contracts & Compliance, Chiesi
CONTINUING EDUCATION
• Industry-specific expertise and CLE, CPE and CCB* accredited content *pending approval
• Dynamic and highly-acclaimed perspectives
• Customizable programming with 3 Pre-Conference Workshops, 2 Summits and 3 Content Workstreams
PROFESSIONAL DEVELOPMENT
• Engage with 250+ like-minded professionals• Multiple peer-to-peer receptions and networking opportunities • Career path conversations and talent development opportunities
BUSINESS INNOVATION
• Real-time industry benchmarking to align best practices• Interactive conference app to enhance the on-site experience
THE MANY REASONS TO JOIN US IN 2020
CONGRESS SPONSORS
Device, Dental and Distributor Transparency Reporting Speaker Program Monitoring Third-Party Risk Management
and Oversight
Guidebook for Beginner’s on Open Payments Reporting
Closed-Door Open Payments Summit — Prelude for Experts
Risk Management in HCP Interactions Global Transparency Reporting Data Collection, Analytics and A.I.
3 PRE-CONFERENCE WORKSHOPS
2 PRE-CONFERENCE SUMMITS
3 TAILORED WORKSTREAMS
Tweet your learnings #AggSpend2020
Join our LinkedIn Community CBI Compliance Series
Another successful conference — excellent opportunity to catch-up with industry friends and hear from my peers! – Manager, Aggregate Spend,
Alcon Laboratories, Inc.
Great conference and venue. Tons of relevant topics and plenty of same-field colleagues looking to remain in compliance with current and future federal/state regulations.– Associate Director, Transparency, UCB
I’m a firm believer that these conferences are the backbone of learning and leveraging knowledge for all peers in the transparency landscape regardless of being Medical Device or Pharma.– Lead Compliance Audit Analyst, Philips Healthcare
In addition to the networking opportunities the conference has a lot to offer from the open forum layout encouraging an exchange of trends, obstacles and wins shared by some well-educated and experienced attendees. – Aggregate Spend Analyst, Chiesi
This was beneficial for our company because we learned best practice on some of our consuming processes. We were able to get some answers to our questions concerning CMS and learned about the new lobbing rules that may affect medical tech.– Sr Global Transparency Specialist, Wright Medical